Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Pulmonary Hypertension, December 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 146 articles:
HTML format


 

Single Articles

  1. KUMARI J, Advani M, Purohit G
    Prevalence of pulmonary hypertension in chronic simple silicosis patients and its correlation with smoking history, occupation type, age and duration of silica exposure.
    Monaldi Arch Chest Dis. 2023 Nov 30. doi: 10.4081/monaldi.2023.2719.
    PubMed    
    Abstract available

  2. ZHANG J, Hu X, Wang T, Xiao R, et al
    Extracellular vesicles in venous thromboembolism and pulmonary hypertension.
    J Nanobiotechnology. 2023;21:461.
    PubMed    
    Abstract available

  3. GOKTEKIN MC, Aksu F, Perilioglu AZ, Akkoc RF, et al
    Relationship of Main Pulmonary Artery (Truncus Pulmonalis) Diameter With Hospital Stay and Mortality in Pulmonary Hypertension Patients Admitted to the Emergency Department.
    Cureus. 2023;15:e47918.
    PubMed    
    Abstract available

  4. KUBOTA K, Imai Y, Okuyama T, Ishiyama Y, et al
    Response to the Letter by Frumkin Regarding the Article, "Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis".
    Int Heart J. 2023;64:1167.
    PubMed    


  5. PRINS KW, Durbin J, Archer SL
    Complete revascularization of the pulmonary circulation in chronic thromboembolic pulmonary hypertension: value of addressing chronic total occlusions.
    Can J Cardiol. 2023 Nov 27:S0828-282X(23)01955.
    PubMed    


  6. TRUONG LN, Santos EW, Zheng YM, Wang YX, et al
    Rieske Iron-Sulfur Protein Mediates Pulmonary Hypertension Following Nicotine/Hypoxia Co-Exposure.
    Am J Respir Cell Mol Biol. 2023 Nov 29. doi: 10.1165/rcmb.2023-0181.
    PubMed    
    Abstract available

  7. WEI E, Chen XH, Zhou SJ
    Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study.
    Front Pediatr. 2023;11:1270712.
    PubMed    
    Abstract available

  8. ZHANG H, Song H
    A 1-month-old infant with pulmonary hypertensive crisis after cardiac surgery was successfully rescued with connection of left atrial and right ventricular pressure measurement tubes: a case report.
    Eur Heart J Case Rep. 2023;7:ytad527.
    PubMed    
    Abstract available

  9. YAMAZAKI Y, Numasawa Y, Mase T, Arai M, et al
    A case of atrial septal defect with right-to-left shunting without pulmonary hypertension.
    J Cardiol Cases. 2023;28:224-227.
    PubMed    
    Abstract available

  10. HADI DD, Marsool MDM, Marsool ADM, Vora N, et al
    Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension.
    Immun Inflamm Dis. 2023;11:e1079.
    PubMed    
    Abstract available

  11. KACHABI A, Colebank MJ, Chesler NC
    Subject-specific one-dimensional fluid dynamics model of chronic thromboembolic pulmonary hypertension.
    Biomech Model Mechanobiol. 2023 Nov 29. doi: 10.1007/s10237-023-01786.
    PubMed    
    Abstract available

  12. PATEL B, D'Souza S, Sahni T, Yehya A, et al
    Pulmonary hypertension secondary to valvular heart disease: a state-of-the-art review.
    Heart Fail Rev. 2023 Nov 29. doi: 10.1007/s10741-023-10372.
    PubMed    
    Abstract available

  13. LUO A, Jia Y, Hao R, Zhou X, et al
    Proteomic and Phosphoproteomic Analysis of Right Ventricular Hypertrophy in the Pulmonary Hypertension Rat Model.
    J Proteome Res. 2023 Nov 28. doi: 10.1021/acs.jproteome.3c00546.
    PubMed    
    Abstract available

  14. PIPER B, Bogamuwa S, Hossain T, Farkas D, et al
    RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension.
    J Clin Invest. 2023 Nov 28:e169441. doi: 10.1172/JCI169441.
    PubMed    
    Abstract available

  15. VILLAMOR E, van Westering-Kroon E, Gonzalez-Luis GE, Bartos F, et al
    Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
    JAMA Netw Open. 2023;6:e2345299.
    PubMed    
    Abstract available

  16. KELLY NJ, Newhouse D, Chapagain H, Patel A, et al
    Omics and Extreme Phenotyping Reveal Longitudinal Association Between Left Atrial Size and Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension.
    J Am Heart Assoc. 2023 Nov 28:e031746. doi: 10.1161/JAHA.123.031746.
    PubMed    
    Abstract available

  17. WANG Q, Su W, Liu J, Zhao D, et al
    Advances in the investigation of the role of autophagy in the etiology of chronic obstructive pulmonary disease: A review.
    Medicine (Baltimore). 2023;102:e36390.
    PubMed    
    Abstract available

  18. PAPADOPOULOS GE, Arvanitaki A, Markidis E, Mouratoglou SA, et al
    Temporal Trends in Diagnostic Hemodynamics and Survival of Patients with Pulmonary Hypertension: A Single-Center Study.
    Life (Basel). 2023;13:2225.
    PubMed    
    Abstract available

  19. LABRADA L, Romero C, Sadek A, Belardo D, et al
    Intravenous Diuresis in Severe Precapillary Pulmonary-Hypertension-Related Right Heart Failure: Effects on Renal Function and Blood Pressure.
    J Clin Med. 2023;12:7149.
    PubMed    
    Abstract available

  20. ARCHAMBAULT JL, Delaney CA
    A Review of Serotonin in the Developing Lung and Neonatal Pulmonary Hypertension.
    Biomedicines. 2023;11:3049.
    PubMed    
    Abstract available

  21. ALRUWAILI N, Kandhi S, Froogh G, Kelly MR, et al
    Superoxide-Mediated Upregulation of MMP9 Participates in BMPR2 Destabilization and Pulmonary Hypertension Development.
    Antioxidants (Basel). 2023;12:1961.
    PubMed    
    Abstract available

  22. SIAMWALA JH, Pagano FS, Dubielecka PM, Ivey MJ, et al
    IL-1beta-mediated adaptive reprogramming of endogenous human cardiac fibroblasts to cells with immune features during fibrotic remodeling.
    Commun Biol. 2023;6:1200.
    PubMed    
    Abstract available

  23. MATSUSHITA FY, Krebs VLJ, de Campos CV, de Vincenzi Gaiolla PV, et al
    Reassessing the role of milrinone in the treatment of heart failure and pulmonary hypertension in neonates and children: a systematic review and meta-analysis.
    Eur J Pediatr. 2023 Nov 24. doi: 10.1007/s00431-023-05342.
    PubMed    
    Abstract available

  24. YE L, Wang B, Xu H, Zhang X, et al
    The Emerging Therapeutic Role of Prostaglandin E2 Signaling in Pulmonary Hypertension.
    Metabolites. 2023;13:1152.
    PubMed    
    Abstract available

  25. REIMANN L, Mayer L, Schneider SR, Schwarz EI, et al
    Change in Right-to-Left Shunt Fraction in Patients with Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Endarterectomy.
    J Cardiovasc Dev Dis. 2023;10:442.
    PubMed    
    Abstract available

  26. ZHOU Y, Chen M, Zheng J, Shui X, et al
    Insights into the relationship between serum uric acid and pulmonary hypertension (Review).
    Mol Med Rep. 2024;29:10.
    PubMed    
    Abstract available

  27. HAN SK, Baik SK, Kim MY
    [Pulmonary Complications in Patients with Liver Cirrhosis].
    Korean J Gastroenterol. 2023;82:213-223.
    PubMed    
    Abstract available

  28. YANG SS, Huang WC, Wang P, Gong FQ, et al
    Echocardiographic measurements of left ventricular dimensions and function in newborns with omphalocele and pulmonary.
    BMC Pediatr. 2023;23:585.
    PubMed    
    Abstract available

  29. ISOBE S, Nair RV, Kang HY, Wang L, et al
    Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension.
    Nat Commun. 2023;14:7578.
    PubMed    
    Abstract available

  30. ZHAO C, Le X, Li M, Hu Y, et al
    Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model.
    Respir Res. 2023;24:289.
    PubMed    
    Abstract available

  31. FRUMKIN LR
    Letter by Frumkin Regarding Article, "Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.".
    Int Heart J. 2023;64:1166.
    PubMed    


  32. ROOKE DA, Kertai MD, Abrams B
    Advancing the Role of the Anesthesiologist in Perioperative Medicine.
    Semin Cardiothorac Vasc Anesth. 2023;27:249-251.
    PubMed    


  33. AUTH R, Klinger JR
    Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension.
    Expert Opin Investig Drugs. 2023;32:1025-1042.
    PubMed    
    Abstract available

  34. FIKRI YA, Mulia EPB, Nugroho FW
    Preoperative Sildenafil in Pediatric Patients Undergoing Congenital Heart Surgeries: A Systematic Review and Meta-Analysis.
    Semin Cardiothorac Vasc Anesth. 2023;27:252-259.
    PubMed    
    Abstract available

  35. RYAN RM, Mukherjee D, Ford S, Lingappan K, et al
    Pharmacotherapy of BPD: Current status & future perspectives.
    Semin Perinatol. 2023;47:151819.
    PubMed    
    Abstract available

  36. WAN M, Lu C, Liu Y, Luo F, et al
    Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism.
    Respir Res. 2023;24:233.
    PubMed    
    Abstract available

  37. SARGENT T, Tsang Y, Panjabi S, Funtanilla V, et al
    Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.
    Adv Ther. 2023;40:5037-5054.
    PubMed    
    Abstract available

  38. NIEMCZYK A, Waskiel-Burnat A, Zaremba M, Czuwara J, et al
    The profile of adipokines associated with fibrosis and impaired microcirculation in systemic sclerosis.
    Adv Med Sci. 2023;68:298-305.
    PubMed    
    Abstract available

  39. GHASOUB R, Benkhadra M, Kassem N, Alshurafa A, et al
    Carfilzomib-induced life-threatening lung injury in refractory multiple myeloma.
    J Oncol Pharm Pract. 2023;29:2041-2044.
    PubMed    
    Abstract available

  40. TAN K, Liu C, Zhao Z, Wang S, et al
    Effectiveness of Halo-Pelvic Traction and Thoracoplasty for Pulmonary Artery Pressure and Cardiopulmonary Function in Patients With Severe Spinal Deformity.
    Clin Spine Surg. 2023;36:E464-E470.
    PubMed    
    Abstract available

  41. QIAN J, Chen Y, Yang X, Wang Q, et al
    Association Study Identified HLA-DQA1 as a Novel Genetic Risk of Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Arthritis Rheumatol. 2023;75:2207-2215.
    PubMed    
    Abstract available

  42. SIMPSON CE, Hemnes AR, Griffiths M, Grunig G, et al
    Metabolomic Differences in Connective Tissue Disease-Associated Versus Idiopathic Pulmonary Arterial Hypertension in the PVDOMICS Cohort.
    Arthritis Rheumatol. 2023;75:2240-2251.
    PubMed    
    Abstract available

  43. GALLO FERNANDEZ I, Rodriguez Nieto J, Perea Armijo J, Pastor Wulf D, et al
    Middle-aged woman with congestive symptoms: more than just pulmonary arterial hypertension.
    Rev Esp Cardiol (Engl Ed). 2023;76:1063-1065.
    PubMed    


  44. ZHANG X, Xiao K, Li L, Wang N, et al
    Hemodynamic factors affecting pulmonary hypertension in hemodialysis patients.
    Kidney Res Clin Pract. 2023 Dec 5. doi: 10.23876.
    PubMed    
    Abstract available

  45. DAI Q, Shang M, Zhou Y, Wei Q, et al
    Evaluation of maternal-fetal outcomes in pregnancy complicated with severe pulmonary hypertension and its influencing factors: a single-center retrospective study in China.
    J Matern Fetal Neonatal Med. 2023;36:2290923.
    PubMed    
    Abstract available

  46. YOSHIMURA N
    [Postoperative Management for Severe Pulmonary Hypertension Associated with Congenital Heart Disease].
    Kyobu Geka. 2023;76:809-813.
    PubMed    
    Abstract available

  47. SHARMA S, Rizwi K, Prasad SN, Meena A, et al
    Systemic arterial to pulmonary arterial shunt masquerading as acute pulmonary embolism.
    BMJ Case Rep. 2023;16:e256008.
    PubMed    


  48. HOU P, Chen HM, Lin SY, Guo WL, et al
    Preliminary study on the short-term changes of pulmonary perfusion after a single balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
    Ther Adv Respir Dis. 2023;17:17534666231212307.
    PubMed    
    Abstract available

  49. ZHANG J, Li Y, Zhang J, Liu L, et al
    ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17.
    Acta Pharm Sin B. 2023;13:4840-4855.
    PubMed    
    Abstract available

  50. LIU H, Wang S, Chen Q, Ge X, et al
    Natural Targeting Potent ROS-Eliminating Tungsten-Based Polyoxometalate Nanodots for Efficient Treatment of Pulmonary Hypertension.
    Adv Healthc Mater. 2023;12:e2303784.
    PubMed    


  51. MADONNA R, Alberti M, Biondi F, Morganti R, et al
    Chronic thromboembolic pulmonary disease: Association with exercise-induced pulmonary hypertension and right ventricle adaptation over time: Chronic thromboembolic pulmonary disease and exercise pulmonary hypertension.
    Eur J Intern Med. 2023 Dec 1:S0953-6205(23)00417.
    PubMed    
    Abstract available

  52. DAYIOGLU M, Gursel G, Ozercan S, Aydin EM, et al
    Performance of handheld ultrasound devices in diagnosis of pulmonary hypertension and right heart dysfunction in ICU patients.
    Echocardiography. 2023 Dec 1. doi: 10.1111/echo.15721.
    PubMed    
    Abstract available

  53. NAKAMURA N, Murakami T, Ishiodori T, Nozaki Y, et al
    Acute exacerbation of pulmonary arterial hypertension after COVID-19 vaccination.
    Pediatr Int. 2023;65:e15711.
    PubMed    


  54. CHANG WT, Lee WC, Lin YW, Shih JY, et al
    Transpulmonary Expression of Exosomal microRNAs in Idiopathic and Congenital Heart Disease-Related Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2023;12:e031435.
    PubMed    
    Abstract available

  55. HOLDEN KI, Martino AM, Guner YS, Harting MT, et al
    Extracorporeal life support in congenital diaphragmatic hernia.
    Semin Pediatr Surg. 2023;32:151328.
    PubMed    
    Abstract available

  56. XU C, Wang B, Li M, Dong Z, et al
    FUNDC1/USP15/Drp1 ameliorated TNF-alpha-induced pulmonary artery endothelial cell proliferation by regulating mitochondrial dynamics.
    Cell Signal. 2024;113:110939.
    PubMed    
    Abstract available

  57. LI Q, Zhang M
    Echocardiography assessment of right ventricular-pulmonary artery coupling: Validation of surrogates and clinical utilities.
    Int J Cardiol. 2024;394:131358.
    PubMed    
    Abstract available

  58. FLING C, De Marco T, Kime NA, Lammi MR, et al
    Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry.
    Ann Am Thorac Soc. 2023;20:1718-1725.
    PubMed    
    Abstract available

  59. LUO J, Sun J, Xu L, Chen J, et al
    Analysis of relationship between P wave dispersion and diagnosis of pulmonary arterial hypertension and risk stratification.
    J Electrocardiol. 2023;81:94-100.
    PubMed    
    Abstract available

  60. GARCIA MVF, Souza R, Caruso P
    Reply to: "Mortality and prognostic factors in connective tissue disease-associated pulmonary arterial hypertension patients complicated with right heart failure".
    Int J Rheum Dis. 2023;26:2612-2614.
    PubMed    


  61. CAJIGAS HR, Lavon B, Harmsen W, Muchmore P, et al
    Quantitative CT measures of pulmonary vascular volume distribution in pulmonary hypertension associated with COPD: Association with clinical characteristics and outcomes.
    Pulm Circ. 2023;13:e12321.
    PubMed    
    Abstract available

  62. TOSUN SONER H, Bulut E, Uzundere O, Soner S, et al
    Management of anesthesia in pregnant women with pulmonary hypertension.
    Eur Rev Med Pharmacol Sci. 2023;27:11315-11322.
    PubMed    
    Abstract available

  63. HANNEMANN J, Freytag J, Schiefer LM, Macholz F, et al
    Asymmetric and symmetric dimethylarginine in high altitude pulmonary hypertension (HAPH) and high altitude pulmonary edema (HAPE).
    Front Physiol. 2023;14:1297636.
    PubMed    
    Abstract available

  64. MA L, Wang Y, Li X, Wang Z, et al
    Tom70-regulated mitochondrial biogenesis via TFAM improves hypoxia-induced dysfunction of pulmonary vascular endothelial cells and alleviates hypoxic pulmonary hypertension.
    Respir Res. 2023;24:310.
    PubMed    
    Abstract available

  65. ZHAO W, Guo J, Dong N, Hei H, et al
    Diagnostic value of 3D volume measurement of central pulmonary artery based on CTPA images in the pulmonary hypertension.
    BMC Med Imaging. 2023;23:211.
    PubMed    
    Abstract available

  66. ZHENG Y, Yuan P, Zhang Z, Fu Y, et al
    Fatty Oil of Descurainia Sophia Nanoparticles Improve Monocrotaline-Induced Pulmonary Hypertension in Rats Through PLC/IP3R/Ca(2+) Signaling Pathway.
    Int J Nanomedicine. 2023;18:7483-7503.
    PubMed    
    Abstract available

  67. KHANGOORA V, Bernstein EJ, King CS, Shlobin OA, et al
    Connective tissue disease-associated pulmonary hypertension: A comprehensive review.
    Pulm Circ. 2023;13:e12276.
    PubMed    
    Abstract available

  68. GASHLER K, Li T, Gonzalez J, Hasoon J, et al
    Anaesthetic considerations: management of pulmonary hypertension and difficult airway in a patient undergoing radical nephrectomy for renal cell carcinoma.
    Anaesthesiol Intensive Ther. 2023;55:307-309.
    PubMed    


  69. WADILE S, Banpurkar A, Kulkarni S
    Trans-catheter closure of an unusual type of Abernethy malformation in a child presenting with severe pulmonary hypertension.
    Cardiol Young. 2023 Dec 12:1-3. doi: 10.1017/S1047951123004006.
    PubMed    
    Abstract available

  70. EBRAHIMI BS, Khwaounjoo P, Argus F, Chan HF, et al
    Predicting Patient Status in Chronic Thromboembolic Pulmonary Hypertension Using a Biophysical Model.
    Annu Int Conf IEEE Eng Med Biol Soc. 2023;2023:1-4.
    PubMed    
    Abstract available

  71. SCHNEIDER SR, Muller J, Bauer M, Mayer L, et al
    Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy.
    Eur Heart J. 2023 Dec 11:ehad789. doi: 10.1093.
    PubMed    


  72. BOCTOR D, Bakke B, Chorba JS
    The Silent Threat: Bartonella quintana Endocarditis Unveiling Heart Failure and Severe Pulmonary Hypertension.
    Am J Case Rep. 2023;24:e942160.
    PubMed    
    Abstract available

  73. MILLIGAN I, Shaw AK, Leu R, Kanaan U, et al
    Prevalence of pulmonary hypertension in obstructive sleep apnea and relation to disease severity.
    J Clin Sleep Med. 2023 Dec 11. doi: 10.5664/jcsm.10952.
    PubMed    
    Abstract available

  74. AUBERT JD, Ulrich S
    Editorial: Challenges in chronic thrombo-embolic pulmonary hypertension (CTEPH).
    Front Med (Lausanne). 2023;10:1326429.
    PubMed    


  75. XI Q, Liu Z, Xiong C, Luo Q, et al
    Pulmonary artery dilatation in different causes of pulmonary hypertension.
    Pulm Circ. 2023;13:e12313.
    PubMed    
    Abstract available

  76. JIA Q, Ouyang Y, Yang Y, Yao S, et al
    Adipokines in pulmonary hypertension: angels or demons?
    Heliyon. 2023;9:e22482.
    PubMed    
    Abstract available

  77. YANG W, Shen J, Shi G, Zhang T, et al
    Bibliometric and visual analysis of hypoxic pulmonary hypertension from 2013 to 2022.
    Heliyon. 2023;9:e22044.
    PubMed    
    Abstract available

  78. GLEESON M, Murray J, Gaine S
    An acute presentation of Chronic Thromboembolic Pulmonary Hypertension complicated by cerebellar infarction.
    Respir Med Case Rep. 2023;46:101931.
    PubMed    
    Abstract available

  79. MOHANTY S, Della Rocca DG, Torlapati PG, Chierchia GB, et al
    Pulsed-Field Ablation Does Not Worsen Baseline Pulmonary Hypertension Following Prior Radiofrequency Ablations.
    JACC Clin Electrophysiol. 2023 Nov 22:S2405-500X(23)00832.
    PubMed    
    Abstract available

  80. ANAND S, Sadek A, Vaidya A, Oliveros E, et al
    Diagnostic Evaluation of Pulmonary Hypertension: A Comprehensive Approach for Primary Care Physicians.
    J Clin Med. 2023;12:7309.
    PubMed    
    Abstract available

  81. JUDINA A, Niglas M, Leonov V, Kirkby NS, et al
    Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function.
    Cells. 2023;12:2764.
    PubMed    
    Abstract available

  82. MATOS JI, Garcia-Rodriguez SN, Costa-Rodriguez N, Caro-Vadillo A, et al
    Usefulness of Tissue Doppler Imaging for the Evaluation of Pulmonary Hypertension in Canine Heartworm Disease.
    Animals (Basel). 2023;13:3647.
    PubMed    
    Abstract available

  83. TAKALDANI AHS, Javanshir N, Honardoost H, Negaresh M, et al
    Extramedullary hematopoiesis in ribs and severe pulmonary hypertension disease following intermediate beta-thalassemia: a case report.
    J Med Case Rep. 2023;17:503.
    PubMed    
    Abstract available

  84. WU YC, Wang WT, Yang MC, Su YT, et al
    The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
    Biol Res. 2023;56:66.
    PubMed    
    Abstract available

  85. HE M, Jiang R, Fei-Sun, Cao JX, et al
    Cardiac magnetic resonance imaging-derived septum swing index detects pulmonary hypertension: A diagnostic study.
    J Transl Int Med. 2023;11:459-467.
    PubMed    
    Abstract available

  86. TONG CX, Meng T
    Twin pregnancy with sudden heart failure and pulmonary hypertension after atrial septal defect repair: A case report.
    World J Clin Cases. 2023;11:8350-8356.
    PubMed    
    Abstract available

  87. SATO K, Shimokawahara H, Matsubara H
    Balloon Pulmonary Angioplasty for a Patient With Central-Type Chronic Thromboembolic Pulmonary Hypertension With Lung Cavitation.
    JACC Cardiovasc Interv. 2023 Dec 8:S1936-8798(23)01548.
    PubMed    


  88. CHEN S, Zhong J, Hu B, Shao N, et al
    Whole-genome microRNA sequencing analysis in patients with pulmonary hypertension.
    Front Genet. 2023;14:1250629.
    PubMed    
    Abstract available

  89. KITAHARA K, Omura J, Wada S, Kim SW, et al
    Correction: Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database.
    Pulm Ther. 2023 Dec 20. doi: 10.1007/s41030-023-00247.
    PubMed    


  90. CONDLIFFE R, Dorfmuller P, Gopalan D, Sitbon O, et al
    From the microscopic to the macroscopic: clinical-radiological-pathological correlation in pulmonary hypertension.
    Eur Respir Rev. 2023;32:230237.
    PubMed    


  91. VERBELEN T, Godinas L, Dorfmuller P, Gopalan D, et al
    Clinical-radiological-pathological correlation in chronic thromboembolic pulmonary hypertension.
    Eur Respir Rev. 2023;32:230149.
    PubMed    
    Abstract available

  92. LICHTBLAU M, Mayer L, Gopalan D, Dorfmuller P, et al
    Clinical-radiological-pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanisms.
    Eur Respir Rev. 2023;32:230119.
    PubMed    
    Abstract available

  93. CONDLIFFE R, Durrington C, Hameed A, Lewis RA, et al
    Clinical-radiological-pathological correlation in pulmonary arterial hypertension.
    Eur Respir Rev. 2023;32:230138.
    PubMed    
    Abstract available

  94. LIU C, Zhou YP, Lian TY, Li RN, et al
    Clonal Hematopoiesis of Indeterminate Potential in Chronic Thromboembolic Pulmonary Hypertension: A Multicenter Study.
    Hypertension. 2023 Dec 20. doi: 10.1161/HYPERTENSIONAHA.123.22274.
    PubMed    
    Abstract available

  95. BERARDI E, Antonica G, Procaccio A, Marziliano D, et al
    Cutaneous polyarteritis nodosa and pulmonary arterial hypertension: An unexpected liaison. A case report.
    Medicine (Baltimore). 2023;102:e36563.
    PubMed    
    Abstract available

  96. BAEK SH, Shin JE, Han J, Song IG, et al
    Factors associated with the response to postnatal dexamethasone use in very low birthweight infants: a nationwide cohort study.
    BMJ Paediatr Open. 2023;7:e002302.
    PubMed    
    Abstract available

  97. QIN Y, Yan G, Qiao Y, Wang D, et al
    Identification of hub genes based on integrated analysis of single-cell and microarray transcriptome in patients with pulmonary arterial hypertension.
    BMC Genomics. 2023;24:788.
    PubMed    
    Abstract available

  98. SINGH N, Eickhoff C, Garcia-Agundez A, Bertone P, et al
    Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension.
    Sci Rep. 2023;13:22534.
    PubMed    
    Abstract available

  99. DAVIS S, Edwards T, Norcross L, Fehnel S, et al
    Use of the National Cancer Institute Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to assess treatment tolerability in pulmonary arterial hypertension: qualitative patient research findings in current and form
    J Patient Rep Outcomes. 2023;7:134.
    PubMed    
    Abstract available

  100. SATO S, Ito T, Tabata T, Ogawa A, et al
    Effect of balloon pulmonary angioplasty on cardio-ankle vascular index and biventricular remodeling in patients with chronic thromboembolic pulmonary hypertension.
    Front Cardiovasc Med. 2023;10:1325846.
    PubMed    
    Abstract available

  101. XU W, Deng M, Xi L, Liu A, et al
    Comparison of cardiovascular metrics on computed tomography pulmonary angiography of the updated and old diagnostic criteria for pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension.
    Quant Imaging Med Surg. 2023;13:7910-7923.
    PubMed    
    Abstract available

  102. MCNEIL AL, Al-Shibli NK, Fuller ME, Goldstein SA, et al
    Pregnancy-related outcomes in obstetric patients with pulmonary hypertension: a single-center retrospective cohort study.
    Int J Obstet Anesth. 2023 Dec 1:103964. doi: 10.1016/j.ijoa.2023.103964.
    PubMed    


  103. HE H, Tong X, Ning Z, Zhou J, et al
    Diffusing capacity of lungs for carbon monoxide associated with subclinical myocardial impairment in systemic sclerosis: A cardiac MR study.
    RMD Open. 2023;9:e003391.
    PubMed    
    Abstract available

  104. ALLAN L, Shanks AM, Polkey M
    Lung infarction secondary to infected pulmonary arterial thrombosis in a patient with Eisenmenger's syndrome.
    BMJ Case Rep. 2023;16:e257803.
    PubMed    
    Abstract available

  105. CHAROENPONG P, Dhillon N, Murnane K, Goeders N, et al
    Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
    BMJ Open Respir Res. 2023;10:e001917.
    PubMed    
    Abstract available

  106. YEGAMBARAM M, Sun X, Lu Q, Jin Y, et al
    Mitochondrial hyperfusion induces metabolic remodeling in lung endothelial cells by modifying the activities of electron transport chain complexes I and III.
    Free Radic Biol Med. 2024;210:183-194.
    PubMed    
    Abstract available

  107. CASTILLO-LARIOS R, Pollak PM, Chaudhary S, Case JB, et al
    Percutaneous Transseptal Extracorporeal Membrane Oxygenation to Rescue a Failing Right Ventricle in an Animal Model.
    Innovations (Phila). 2023;18:583-588.
    PubMed    
    Abstract available

  108. MCEVOY C, Argula R, Sahay S, Shapiro S, et al
    Tyvaso DPI: Drug-device characteristics and patient clinical considerations.
    Pulm Pharmacol Ther. 2023;83:102266.
    PubMed    
    Abstract available

  109. COLAK A, Erdemir AG, Hazirolan T, Pirat B, et al
    Multiparametric assessment of right ventricular function in heart transplant recipients by echocardiography and relations with pulmonary hemodynamics.
    Echocardiography. 2023;40:1350-1355.
    PubMed    
    Abstract available

  110. HUANG J, Xie Y, Chen B, Xia Y, et al
    GPR146 regulates pulmonary vascular remodeling by promoting pulmonary artery smooth muscle cell proliferation through 5-lipoxygenase.
    Eur J Pharmacol. 2023;961:176123.
    PubMed    
    Abstract available

  111. XING YY, Ruan Y, Qin H, Zhao L, et al
    Effects of maternal pulmonary arterial hypertension on fetal hemodynamics and maternal-fetal outcome in late pregnancy.
    Echocardiography. 2023;40:1339-1349.
    PubMed    
    Abstract available

  112. LI D, Chen Y, Wang Y, Liu J, et al
    NAMPT mediates PDGF-induced pulmonary arterial smooth muscle cell proliferation by TLR4/NF-kappaB/PLK4 signaling pathway.
    Eur J Pharmacol. 2023;961:176151.
    PubMed    
    Abstract available

  113. ZHANG Y, Lin Z, Chen Y, Hong L, et al
    Factors related to pre-operative cough strength in cardiac surgical patients: a cross-sectional study.
    Heart Lung. 2024;63:128-135.
    PubMed    
    Abstract available

  114. MUHLFELD C, Bienas LM, Bornemann M, Schipke J, et al
    Chronic hypoxia-induced alterations of the right ventricular myocardium are not aggravated by alimentary obesity in the mouse.
    Microvasc Res. 2024;151:104618.
    PubMed    
    Abstract available

  115. ABEL P, Bulow R, Stubbe B, Heine A, et al
    [Fatal course of pulmonary embolism after successful pulmonary endarterectomy: a rare case].
    Pneumologie. 2023;77:1009-1012.
    PubMed    
    Abstract available

  116. SUGITANI Y, Muneuchi J, Watanabe M
    Home-inhaled nitric oxide in a child with pulmonary arterial hypertension associated with post-operative pulmonary venous obstruction.
    Cardiol Young. 2023;33:2673-2675.
    PubMed    
    Abstract available

  117. ABAGNALE L, Candia C, Motta A, Galloway B, et al
    Flow-mediated dilation as a marker of endothelial dysfunction in pulmonary diseases: A narrative review.
    Respir Med Res. 2023;84:101049.
    PubMed    
    Abstract available

  118. TSANG Y, Stokes M, Kim YJ, Tilney R, et al
    Impact of selexipag use within 12 months of pulmonary arterial hypertension diagnosis on hospitalizations and medical costs: A retrospective cohort study.
    Clin Respir J. 2023;17:1209-1222.
    PubMed    
    Abstract available

  119. PURMESSUR R, Spencer H, Onwuka NB, Muthialu N, et al
    From 6-wk Lungs to 6 y: Increasing the Donor Pool for Pediatric Lung Transplantation.
    Transplantation. 2023 Oct 4. doi: 10.1097/TP.0000000000004815.
    PubMed    
    Abstract available

  120. HE X, Fang J, Gong M, Zhang J, et al
    Identification of immune-associated signatures and potential therapeutic targets for pulmonary arterial hypertension.
    J Cell Mol Med. 2023;27:3864-3877.
    PubMed    
    Abstract available

  121. LIU C, Wan N, Wei L, Rong W, et al
    Therapeutic potential and protective role of GRK6 overexpression in pulmonary arterial hypertension.
    Vascul Pharmacol. 2023;153:107233.
    PubMed    
    Abstract available

  122. LI HR, Chen GL, Fang XL, Cai XJ, et al
    Circ_0068481 Affects the Human Pulmonary Artery Smooth Muscle Cells' Progression by miR-361-3p/KLF5 Axis.
    Am J Hypertens. 2024;37:33-45.
    PubMed    
    Abstract available

  123. HE YZ, Wang YX, Ma JS, Li RN, et al
    MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension.
    Vascul Pharmacol. 2023;153:107216.
    PubMed    
    Abstract available

  124. KOPEC G
    Sotatercept as a next-generation therapy for pulmonary arterial hypertension: insights from the STELLAR trial.
    Cardiovasc Res. 2023;119:e155-e157.
    PubMed    


  125. ZHANG J, Meng H, Yin Y, Zhang Y, et al
    Prevalence and Determinants of Delay in Time-to-Diagnosis for Pulmonary Arterial Hypertension Patients in Gansu China: A Observational Cohort Study.
    Curr Probl Cardiol. 2023;48:102026.
    PubMed    
    Abstract available

  126. NISAR S, Kareem O, Muzaffer U, Tanvir M, et al
    Descriptive spectrum of thiamine deficiency in pregnancy: A potentially preventable condition.
    Int J Gynaecol Obstet. 2023 Jul 17. doi: 10.1002/ijgo.14989.
    PubMed    
    Abstract available

  127. RUBENS M, Ramamoorthy V, Saxena A, Jimenez J, et al
    Hospital Outcomes Among Pulmonary Hypertension Patients with Atrial Fibrillation in the United States.
    Am J Cardiol. 2023 Nov 29:S0002-9149(23)01347.
    PubMed    
    Abstract available

  128. KIKUCHI H, Goda A, Takeuchi K, Inami T, et al
    Transition from Intravenous Epoprostenol to Treprostinil Due to Intolerable Side Effects in Patients With Pulmonary Arterial Hypertension.
    Am J Cardiol. 2023;206:31-34.
    PubMed    
    Abstract available

  129. YASUMA T, Fujimoto H, D'Alessandro-Gabazza CN, Gabazza EC, et al
    Epoprostenol and Treprostinil: Differential Effects on Regulatory T-Cell Generation in Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;208:1248.
    PubMed    


  130. WEATHERALD J, Moutchia J, Al-Naamani N, McClelland RL, et al
    Win Statistics in Pulmonary Arterial Hypertension Clinical Trials.
    Am J Respir Crit Care Med. 2023;208:1231-1234.
    PubMed    


  131. LUI JK, Cozzolino M, Winburn M, Trojanowski MA, et al
    Role of Left Ventricular Dysfunction in Systemic Sclerosis-related Pulmonary Hypertension.
    Chest. 2023 Dec 19:S0012-3692(23)05932-9. doi: 10.1016/j.chest.2023.
    PubMed    
    Abstract available

  132. FAUVEL C, Liu Y, Correa-Jaque P, Kanwar MK, et al
    Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.
    Chest. 2023;164:1518-1530.
    PubMed    
    Abstract available

  133. KNIGHT H, Abis G, Kaur M, Green HLH, et al
    Cyclin D-CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation.
    Circ Res. 2023;133:966-988.
    PubMed    
    Abstract available

  134. WALTERS R, Vasilaki E, Wilkins MR, Zhao L, et al
    Response by Walters et al to Letter Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1825-1826.
    PubMed    


  135. LI G, Chen H, Ren C
    Letter by Li et al Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1823-1824.
    PubMed    


  136. ATCHLEY WT, Kakkera TK
    Pulmonary hypertension in chronic obstructive pulmonary disease: current understanding, knowledge gaps and future directions.
    Curr Opin Pulm Med. 2023 Dec 14. doi: 10.1097/MCP.0000000000001041.
    PubMed    
    Abstract available

  137. PAUSCH C, Pittrow D, Hoeper MM, Huscher D, et al
    Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.
    Eur Respir J. 2023;62:2301023.
    PubMed    
    Abstract available

  138. CELANT LR, Wessels JN, Kianzad A, Marcus JT, et al
    Restoration of right ventricular function in the treatment of pulmonary arterial hypertension.
    Heart. 2023;109:1844-1850.
    PubMed    
    Abstract available

  139. MOHANANEY D, Martin AK, Mandawat H, Hauser JM, et al
    Analysis of the 2022 European Society of Cardiology/European Respiratory Society Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.
    J Cardiothorac Vasc Anesth. 2023 Nov 3:S1053-0770(23)00906.
    PubMed    


  140. KIANZAD A, Baccelli A, Braams NJ, Andersen S, et al
    Long-term effects of pulmonary endarterectomy on pulmonary hemodynamics, cardiac function and exercise capacity in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2023 Nov 22:S1053-2498(23)02130.
    PubMed    
    Abstract available

  141. TAKANO R, Aoki T, Asano R, Ueda J, et al
    Recurrent Pulmonary Hypertension After Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 Dec 19:S1053-2498(23)02174.
    PubMed    
    Abstract available

  142. JUTANT EM, Chelgham MK, Ottaviani M, Thuillet R, et al
    Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension.
    J Heart Lung Transplant. 2024;43:120-133.
    PubMed    
    Abstract available

  143. VALDEOLMILLOS E, Le Pavec J, Audie M, Savale L, et al
    Thirty years of surgical management of pediatric pulmonary hypertension :mid-term outcomes following reverse Potts shunt and transplantation.
    J Thorac Cardiovasc Surg. 2023 Dec 3:S0022-5223(23)01121.
    PubMed    
    Abstract available

  144. MONTANI D, Eichstaedt CA, Belge C, Chung WK, et al
    [Genetic counselling and testing in pulmonary arterial hypertension - A consensus statement on behalf of the International Consortium for Genetic Studies in PAH - French version].
    Rev Mal Respir. 2023;40.
    PubMed    
    Abstract available

  145. MARIN-ROMERO S, Ballaz-Quincoces A, Gomez-Cuervo C, Marchena-Yglesias PJ, et al
    Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study.
    Thorax. 2023 Nov 30:thorax-2023-220580. doi: 10.1136/thorax-2023-220580.
    PubMed    
    Abstract available

  146. BARTNIK A, Pepke-Zaba J, Bunclark K, Ruggiero A, et al
    Cardiac MRI in the assessment of chronic thromboembolic pulmonary hypertension and response to treatment.
    Thorax. 2023 Nov 22:thorax-2022-219716. doi: 10.1136/thorax-2022-219716.
    PubMed    



Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.


;